CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
The S&P/ASX 200 (INDEXASX: XJO) started Tuesday with a mixed day. The ASX 200 price was up 0.3% with the EML Payments Ltd (ASX:EML) share price and Link (ASX:LNK) share price in focus.
The Australian share market, otherwise known as S&P/ASX 200 (INDEXASX: XJO) or All Ordinaries (INDEXASX: XAO), continued on a downward trend on Wednesday, to open the month of June by falling 0.8 per cent.
It’s been a crazy few months, hasn’t it? Rates, Elections, inflation… Here’s how I’m investing right now.
The ASX 200 (ASX:XJO) couldn’t overcome growing concerns about stagflation on Thursday as Ramsay (ASX:RHC) and Webjet (ASX:WEB) made headlines.
The technology sector all but sunk the S&P/ASX 200 (ASX: XJO) on Thursday as CommBank (ASX:CBA) and Xero (ASX:XRO) shares were in the news.
The S&P/ASX 200 (INDEXASX:XJO) eked out a small gain on Wednesday as Link (ASX:LNK) and Magellan (ASX:MFG) shares were in the news.
The S&P/ASX 200 (ASX:XJO) fell another 1.2% to start the week as Westpac (ASX:WBC) and Magellan (ASX:MFG) shares made headlines.
The S&P/ASX 200 (ASX: XJO) was muted in response to Australia’s first interest rate rise in over a decade. Here’s what you need to know.
The S&P/ASX 200 (ASX: XJO) is set to open lower this morning as Ramsay (ASX:RHC) and BHP (ASX:BHP) shares have been making headlines.
